ReviewThe Korean journal of internal medicine2025
Current perspectives on sarcopenia: diagnosis and therapeutic approaches.
Review in The Korean journal of internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sarcopenia and Frailty in COPD: Mechanisms, Relationship with Malnutrition and Potential Therapeutic Interventions.Nutrients · 2026Review
- Effectiveness of digital health exercise interventions on muscle function and physical performance in older adults with possible, confirmed, or severe sarcopenia: a systematic review and meta-analysis.European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Korea is experiencing rapid population aging and entered a super-aged society in December 2024. This demographic shift underscores the growing prevalence of sarcopenia, a progressive skeletal muscle disorder related to aging, characterized by reduced muscle mass, strength, and function, which significantly affects the morbidity and quality of life of older adults. Although sarcopenia is defined as a medical condition (ICD-10-CM M62.84; KCD-8 M62.5), no effective pharmacological treatment exists, emphasizing the importance of non-pharmacological prevention and management strategies. Definitions of sarcopenia have been proposed by the European Working Group on Sarcopenia in Older People (EWGSOP), the Asian Working Group for Sarcopenia (AWGS), and the Korean Working Group on Sarcopenia (KWGS). The current interventions focus on exercise and nutritional supplementation. Protein intake above the generally recommended dietary allowance, along with resistance exercise, is strongly recommended for the prevention and management of sarcopenia. Asian intervention studies have highlighted the benefits of multimodal programs that combine exercise, nutrition, and geriatric care. However, standardized protocols remain inconclusive. Variations in diagnostic criteria and ethnic differences further complicate the management of sarcopenia. Future large-scale studies are needed to establish effective preventive measures and therapeutic strategies for sarcopenia with a focus on tailored interventions and standardized protocols for Asians.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.